Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT ID: NCT06285838
Last Updated: 2024-02-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11000 participants
OBSERVATIONAL
2020-07-17
2024-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A policy decision was made that essential surgical services pertaining to cancer and urgent cardiovascular surgery were allowed but that surgeons had the option to postpone what is assessed to be less urgent cases. Increasingly patients also postpone their surgeries or visits because of anxieties over the developing situation. Elective surgical services at the Outram Campus were thus significantly reduced from January 2020 as part of the measures to contain the COVID-19 outbreak.
The surgical philosophy during this period was that a judicious policy that allowed surgeons to proceed with surgery deemed critical but to postpone those deemed less so will at the system level, avoid poor outcomes for patients who required surgery and yet successfully re-allocate resources required to address the unfolding pandemic.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
-1Jan-31Dec2020 -1Jan-31Dec2019 -1Jan-31Dec2018 -1Jan-31Dec2017
The study focus on surgical indices for selected high-volume cancer and non-cancer diagnoses over the period 1st January 2020 to 31 December 2020 and compare them with similar indices across the same period of time in the preceding 3 years in particular, for the following surgical procedures:
1. Surgeries for the following cancer diagnoses:
1. breast cancer, \[XIV- N60, no malignancy\], \[Malignant, II Neoplasms- C50\], colorectal cancer, \[C18, 19, 20\],
2. hepatocellular carcinoma, \[C22\]
2. Selected non-cancer surgeries: a. Cholecystectomy b. Abdominal hernia repair
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
From the identified surgical procedure type as shown Surgeries for the following cancer-related procedures.
1. Breast Cancer
2. Colon Cancer
3. Liver
4. Rectum
Selected non-cancer surgeries.
1. Abdominal Wall
2. Gall bladder
Patients from SGH and its releated institute NCC Only local Singapore citizens
Exclusion Criteria
21 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Singapore Health Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sean Shao Wei Lam
Deputy Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore Health Services Pte ltd
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mazingi D, Navarro S, Bobel MC, Dube A, Mbanje C, Lavy C. Exploring the Impact of COVID-19 on Progress Towards Achieving Global Surgery Goals. World J Surg. 2020 Aug;44(8):2451-2457. doi: 10.1007/s00268-020-05627-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/2706
Identifier Type: -
Identifier Source: org_study_id